The Valley Desk

ArticleVirusesPublished

A Novel Rotavirus Reverse Genetics Platform Supports Flexible Insertion of Exogenous Genes and Enables Rapid Development of a High-Throughput Neutralization Assay

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Merck & Co. Affiliation source

Institution
Merck & Co.

Publication record

Type
Article
Venue
Viruses
Published
Subject terms
Animals; Humans; Rotavirus; Rotavirus Infections; Rotavirus Vaccines; Genes, Reporter; Child; Reverse Genetics; Neutralizing antibody; High-throughput screening; Pre-existing Immunity; Microneutralization Assay
PubMed ID
37896813
PubMed Central ID
PMC10611407
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal